biocon cmd kiran mazumdar shaw discusses biocon's q3 results - zee business
Published 12 years ago • 29 plays • Length 6:51Download video MP4
Download video MP3
Similar videos
-
6:14
biocon cmd kiran mazumdar shaw discussing the h1fy13 results on zee business
-
1:41
kiran mazumdar shaw, biocon results q1fy10 zee business, pharmaceutical
-
3:39
biocon: q3fy16: cmd- kiran mazumdar shaw - zeebiz
-
17:43
live: kiran mazumdar shaw on biocon q3 results, viatris deal & drug regulation in india
-
5:20
have to strategise with a view to lead, not follow: biocon & biocon biologies | cnbc tv1
-
19:40
seeing 20% rise in demand for our insulin pdts in us: biocon & biocon biologies | cnbc tv18
-
5:23
biocon eyes equity investments for debt reduction says kiran mazumdar-shaw | exclusive | cnbc tv18
-
11:49
biocon's kiran mazumdar shaw on q3 results
-
5:47
biocon limited q3 numbers are out | kiran mazumdar shaw speaks to et now
-
4:20
biocon h1fy13 results zeebiz 1120am oct31
-
0:41
biocon h1fy13 results zeebiz 0920pm oct31
-
6:14
biocon h1fy13 results - live interview zeebiz 1215pm oct31
-
1:32
biocon: q2fy17: cmd- kiran mazumdar shaw - zeebiz
-
0:32
biocon h1fy13 results zeebiz 0715am oct30
-
7:01
biocon q3 net profit falls 25%, revenue jumps 36%: kiran mazumdar shaw exclusive | cnbc-tv18
-
6:50
biocon's kiran mazumdar shaw on strong q4, biosimilar business & fy24 outlook | halftime report
-
4:16
company is exploring equity investment opportunities to reduce debt: biocon's kiran mazumdar-shaw
-
1:44
biocon h1fy13 results etnow 0735am oct31
-
12:10
biocon's kiran mazumdar shaw discusses biosimilar opportunities, 2023 outlook | cnbc-tv18
-
0:45
biocon h1fy13 results zeebiz 0520pm oct31
-
7:56
biocon q4: muted growth in generic business | review by kiran mazumdar shaw | business news